Sean Khozin, MD, MPH is a physician-scientist, oncologist, and investor focused on advancing innovations at the intersection of biology, technology, and artificial intelligence/machine learning.

Before his tenure in the US federal government, Dr. Khozin was the cofounder of Hello Health, a pioneering TechBio company focused on developing telemedicine, point-of-care data visualization, and analytical systems as an integrated approach for optimizing patient care, drug discovery, and clinical research. The company’s core technology offerings were first operationalized in a multidisciplinary network of clinics he had founded called SKMD.

Dr. Khozin is a Research Affiliate at MIT, where he combines his quantitative and life sciences expertise in support of novel solutions for improving the lives of patients with cancer. He has a decade of clinical and basic science research experience at the US National Cancer Institute, having started his clinical research work developing molecular profiling strategies for advancing the use of targeted therapies in thoracic malignancies.

Eric Schultz has been at the forefront of disruptive innovation in technology since the 1980s, building innovative products, services, and companies. From his early work that ushered in the age of the PC to developing cutting-edge artificial intelligence platforms for human genomics, he has led breakthrough initiatives in desktop and connected computing, distributed security systems, smartphones and the mobile internet, massive online learning communities, real-world evidence, precision medicine, and AI-driven digital biology. He founded and built several startups (Blossom, Mesa, Wireless Knowledge, QuantiaMD, Cota, Ocean Genomics) and served in executive roles at leading companies (ADT, Lotus, Microsoft, and Qualcomm).

Since 2004, Eric has focused exclusively on healthcare and life sciences, leveraging real-world evidence and the artful application of AI and machine learning to improve the lives of patients. Most recently, he co-founded Ocean Genomics, a digital biology company spun out from Carnegie Mellon, focusing on transcriptomics and AI. Prior to Ocean, Eric co-founded Cota Healthcare as CEO with a group of leading oncologists to advance precision medicine and drug development by building research-grade real-world evidence from the data and documents stored in EMRs and other clinical systems within large cancer centers and practices.

Sameer Lal is the Sr VP and head of the Enterprise Medical Business Unit at Indegene focusing on services to Medical Affairs, Safety, Regulatory and Market Access organizations in life sciences companies. Sameer drives the overall P&L through sales and marketing efforts, capability building, innovation and delivery. He is currently leading the charge in his organization for Generative AI with creation of Innovation teams, Communities of Practice and Power Users to drive specific use cases with clients.

Sameer has over twenty-seven years of experience both in the pharmaceutical industry as well as on the services side. Prior to joining Indegene, Sameer has served a variety of leadership roles in companies like GlaxoSmithKline and Sudler & Hennessey. His expertise lies in building long-term strategic client relationships, developing strategic roadmaps for sustained business growth, and effectively executing against set objectives.

Nitya works at Amgen where she has supported commercial efforts including primary market research, analytics and forecasting. She has also worked on analysis of eligibility criteria across oncology clinical trials to drive patient recruitment. Outside of Amgen, Nitya is the NYC lead for a group called Bits in Bio for folks working on software across biology and in biotech. Events for the group range from hackathons to product panels to lightning talks from members. Nitya is most interested in using technology to ensure a close understanding of the patient journey and driving targeted commercial efforts, so all patients receive the medication or trial access that can improve their quality of life.